Top Markets
Coin of the day
Roche Holding AG Roche Holding AG

Roche Holding AG

ROG
Rank in Stocks #37
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in... Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.
Share Price
$419.17
Market Cap
$333.66B
Change (1 day)
0.50%
Change (1 year)
14.13%
Country
CH
Trade Roche Holding AG (ROG)

Category

P/S ratio for Roche Holding AG (ROG)
P/S ratio as of February 2026 TTM: 4.66
According to Roche Holding AG latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.66. At the end of 2024 the company had a P/S ratio of 3.26.
P/S ratio history for Roche Holding AG from 2000 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
2026 (TTM) 4.66 9.61%
2025 4.25 30.13%
2024 3.26 0.97%
2023 3.23 -11.99%
2022 3.67 -28.43%
2021 5.13 13.27%
2020 4.53 7.44%
2019 4.22 17.85%
2018 3.58 -5.15%
2017 3.77 0.18%
2016 3.77 -19.32%
2015 4.67 1.56%
2014 4.60 5.71%
2013 4.35 23.08%
2012 3.53 11.14%
2011 3.18 28.80%
2010 2.47 -20.71%
2009 3.11 1.57%
2008 3.06 -15.88%
2007 3.64 -17.75%
2006 4.43 -5.68%
2005 4.69 33.45%
2004 3.52 4.93%
2003 3.35 23.31%
2002 2.72 -20.37%
2001 3.41 -29.43%
2000 4.84 0.00%
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country